Beam Therapeutics Inc (BEAM)

NASDAQ
44.00
-0.10(-0.22%)
  • Volume:
    276,971
  • Day's Range:
    42.89 - 44.76
  • 52 wk Range:
    27.77 - 88.18

BEAM Overview

Prev. Close
44.1
Day's Range
42.89-44.76
Revenue
91.95M
Open
44.73
52 wk Range
27.77-88.18
EPS
-4.55
Volume
276,971
Market Cap
3.02B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
883,868
P/E Ratio
-10.30
Beta
1.66
1-Year Change
-43.94%
Shares Outstanding
68,821,182
Next Earnings Date
Feb 27, 2023
What is your sentiment on Beam?
or
Vote to see community's results!

Beam Therapeutics Inc News

Beam Therapeutics Inc Analysis

Beam Therapeutics Inc Company Profile

Beam Therapeutics Inc Company Profile

Employees
476

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children’s Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Read More

Analyst Price Target

Average80.08 (+83.12% Upside)
High125.00
Low49.00
Price43.73
No. of Analysts13
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellSellStrong BuyStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • the interesting thing to note is how BEAM after weeks of going up, went down late Friday afternoon prior announcement from FDA. This speaks volumes that there are leaks that are given to some and they benefit from those leaks. I was short as it is a ridiculous valuation given the negative earnings but Cathy Wood kept driving up the price.
    0
    • What fda announcement?
      0
    • halted BEAM clinical trial on Monday morning. tell me the Paul Pelosi's of the world did not get a heads up on this on Friday.
      0
  • The mystery of BEAM. The one agreement they have is with VERVE which just went down by 10%
    0
    • i know, and? their earnings are still negative since agreement signed in Dec and the agreement calls for certain milestones to be met in order to get paid.
      0
    • great long term play but very pricey given where they are financially and Verve just doing trials (the one licensee).
      0
    • And? Most clinical stage Bios have negative earnings. This was trading at 150 a share last year and if a positive catalyst comes out it will easily go over 100. Since when does every stock have to have a so called "fair" valuation?
      0
  • it defies logic. Cathy driving up the price artificially
    0
    • i dont understand what makes BEAM attractive at $50 valuations. $4B cap for a company with $60M in sales and -$400M in revenue. What am I missing that causes this stock to go up when companies with revnue and earnings are going down?
      0
      • cas12
        0
      • in English please?
        0
    • ok, i enter in 90.05🚀🚀🚀
      0
      • Hang on to this and build off the Bio Tech. Today is your lucky day. I am about to share some very valuable info with you. Use it wisely!! Its going to make you rich. Y am i telling you and only you?? Lol. I want to!! Use it wisely!! CSPR, EDIT,BEAM,BNGO,PACB… That is the FUTURE, not EVs. Its about Health. Making vaccines, ending bio threat. Its immediate. Good luck bud. Read up on this. You will be good
        0
      • Ray Weberit all crashed
        0
      • Did you hold?
        0
    • Fly zone!! Bio tech
      0
      • Volume🌋
        0
        • WHY IT IS QUITE IN HERE? ANY WORD ON THIS STOCK?
          0
          • is there bad news about this stock causing it dropping?
            0
            • no, it's still a great buy long term. Their technology is great (check out doctors on youtube talking about it)
              0
          • Buy now thank me later 🚀
            0
            • l
              0
            • Anyone that bought because you told them, is not at a loss
              0